HomeVenture Capital

Venture Capital

Venture Capital

Normunity Announces $65 Million Series a Financing to Expand the Frontier of Precision Immuno-Oncology With Immune Normalizer Therapies

Life Sciences Times - 0
Venture Capital

Alto Neuroscience Announces $35 Million Series B Financing

Life Sciences Times - 0
Venture Capital

WhizAI Closes New Round with Investment from Shanda Group and AmerisourceBergen Bringing Total Capital Raised to $21 Million

Life Sciences Times - 0
Venture Capital

SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options

Life Sciences Times - 0
Venture Capital

CitiusTech Announces Investment and Strategic Partnership from Bain Capital Private Equity

Life Sciences Times - 0
Venture Capital

PIC Therapeutics Completes $35 Million Series A Financing to Develop Treatments for Drug-Resistant Breast Cancer

Life Sciences Times - 0
Venture Capital

Orionis Biosciences Secures $55 Million Financing to Support Advancement into Clinic

Life Sciences Times - 0
Venture Capital

Variantyx Secures Additional $20M from Kreos Capital, Following $41.5M Investment Round

Life Sciences Times - 0
Venture Capital

Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform to Advance Pipeline of Neuroactive Compounds Targeting CNS Disorders

Life Sciences Times - 0
Venture Capital

Resource Label Group Expands Pharmaceutical Offering With Acquisition of MedLit Solutions

Life Sciences Times - 0
Venture Capital

Xentria Announces $25 Million Equity Financing Round to Advance Pipeline and Execute on Growth Strategy

Life Sciences Times - 0
Venture Capital

Tivic Health to Acquire Assets of Reliefband

Life Sciences Times - 0
1...626364...115Page 63 of 115

Most Read